Jubilant Pharmova consolidated net profit rises 51.05% in the December 2024 quarter

Explore Business Standard
Associate Sponsors

Sales rise 8.92% to Rs 1813.70 crore
Net profit of Jubilant Pharmova rose 51.05% to Rs 100.90 crore in the quarter ended December 2024 as against Rs 66.80 crore during the previous quarter ended December 2023. Sales rose 8.92% to Rs 1813.70 crore in the quarter ended December 2024 as against Rs 1665.20 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales1813.701665.20 9 OPM %15.8313.09 -PBDT240.70195.60 23 PBT149.40101.00 48 NP100.9066.80 51Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Jan 31 2025 | 2:39 PM IST